BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

CUSIP: 10806X102

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
-2,506,981
Put/Call ratio
45%
SEC-reported price per share
$9.08
Number of holders
153
Value change
-$23,547,672
Number of buys
71
Open additional details 1 more signal available
Number of sells
76
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
195,844,380

Security key

10806X102

Report period

Q2 2022

Institutions

153

Top holders

10

Ownership snapshot

Top reported holders of BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kohlberg Kravis Roberts &...
Disclosed value leader
Kohlberg Kravis Roberts &...
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 16% Showing 1-6 of 15 holder rows.

Quick read

Kohlberg Kravis Roberts & Co. L.P. leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kohlberg Kravis Roberts & Co. L.P.'s linked filing trail.
Comparable ownership Top 5
Kohlberg Kravis Roberts & Co. L.P. 16%
VIKING GLOBAL INVESTORS LP 14%
VANGUARD GROUP INC 4.8%
STATE STREET CORP 4.7%
BlackRock Finance, Inc. 4.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
13F
16%
$315,269,000
31,060,971 shares
31 Mar 2022
VIKING GLOBAL INVESTORS LP
13F
Company
13F
14%
$270,203,000
26,620,991 shares
31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
4.8%
$95,655,000
9,424,112 shares
31 Mar 2022
STATE STREET CORP
13F
Company
13F
4.7%
$93,443,000
9,206,234 shares
31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
4.7%
$92,815,000
9,144,207 shares
31 Mar 2022
Aisling Capital Management LP
13F
Company
13F
3.1%
$61,591,000
6,068,125 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
153
Shares
140,449,294
Rows available
153
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
167
Q2 2022 holders
153
Holder diff
-14
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .